Prostate News Archive
30-Aug-2008
Hormone Therapy May Speed Prostate Cancer (WebMD)
Hormone therapy can speed prostate cancer spread. University of Rochester researchers say their findings "may revolutionize the way we combat prostate cancer." Dana-Farber/Brigham And Women's Cancer Center Experts Webcast 10th Annual Patient Education Event On Prostate Cancer (Medical News Today)
On September 10, 2008, at 6 p.m. E.T., leading prostate cancer specialists from Dana-Farber/Brigham and Women's Cancer Center will webcast their 10th Annual Symposium on prostate Cancer, a patient education event featuring the newest advances in treatment, screening, and prevention of prostate cancer. For this webcast, Anthony V. Randomized Phase 2 Study Of IMC-A12 And IMC-1121B For Advanced Prostate Cancer Commences Patient Enrollment (Medical News Today)
ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that its disease-directed Phase 2 clinical trial in patients with advanced prostate cancer randomized to treatment with either IMC-A12 or IMC-1121B plus mitoxantrone and prednisone has commenced patient enrollment. Annual test for prostate cancer (Bromsgrove Standard)
Prostate Cancer is the most common form of cancer affecting men with approximately 35,000 new cases diagnosed each year - an average of 150 new cases every working day. Health Risk Behaviors Associated With Lower Prostate Specific Antigen Awareness (Medical News Today)
According to a study conducted at Columbia University Mailman School of Public Health, health risk behaviors such as smoking and obesity are associated with lower awareness of the prostate Specific Antigen (PSA), which could lead to a lower likelihood of undergoing actual prostate cancer screening.
Back to Prostate News Archive
